4//SEC Filing
Hanson Jason David 4
Accession 0001246360-12-004867
CIK 0000859368other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 9:00 PM ET
Size
5.2 KB
Accession
0001246360-12-004867
Insider Transaction Report
Form 4
Hanson Jason David
EVP,General Counsel & Corp Sec
Transactions
- Disposition to Issuer
Common Stock
2012-12-11$44.00/sh−225,513$9,922,572→ 0 total
Footnotes (1)
- [F1]On December 11, 2012, the Issuer completed its merger (the "Merger") with Valeant Pharmaceuticals International ("Valeant"), whereby the Issuer became a wholly owned subsidiary of Valeant, pursuant to an Agreement and Plan of Merger that was entered into on September 2, 2012 (the "Merger Agreement"). In accordance with the Merger Agreement, each share of common stock of the Issuer issued and outstanding immediately prior to the consummation of the Merger converted into a right to receive an amount in cash equal to $44.00 per share (the "Per Share Merger Consideration"), without interest. The amount of shares in Column 4 includes 225,513 restricted shares of common stock that also converted into a right to receive the Per Share Merger Consideration.
Documents
Issuer
MEDICIS PHARMACEUTICAL CORP
CIK 0000859368
Entity typeother
Related Parties
1- filerCIK 0001368586
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 9:00 PM ET
- Size
- 5.2 KB